Pooled Results of Two Randomized Phase III Trials Evaluating VP-102, a Drug-Device Combination Product Containing Cantharidin 0.7% (w/v) for the Treatment of Molluscum Contagiosum

BACKGROUND: Compounded cantharidin has been used for decades to treat molluscum contagiosum but lacks rigorous clinical evidence to support its safety and efficacy. VP-102 is a shelf-stable drug–device combination product that contains topical cantharidin (0.7% weight/volume [w/v]) and is being eval...

Descripción completa

Detalles Bibliográficos
Autores principales: Eichenfield, Lawrence F., Siegfried, Elaine, Kwong, Pearl, McBride, Mark, Rieger, Jayson, Glover, David, Willson, Cynthia, Davidson, Matthew, Burnett, Patrick, Olivadoti, Melissa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973914/
https://www.ncbi.nlm.nih.gov/pubmed/33599960
http://dx.doi.org/10.1007/s40257-020-00570-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973914/
https://www.ncbi.nlm.nih.gov/pubmed/33599960
http://dx.doi.org/10.1007/s40257-020-00570-8

Ejemplares similares